Conservative or Operative Therapy in Patients With a Fragility Fracture of the Pelvis

Sponsor
Björn-Christian Link (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04744350
Collaborator
(none)
68
2
30

Study Details

Study Description

Brief Summary

In our society the population consists of more elderly patients. Medical treatment needs to be adjusted to this patient group. This research project focusses on patients with a fragility fracture of the pelvis. This results from a minor trauma and can cause a long immobilization period because of severe pain. For FFP type II b and II c there is no consensus on the best treatment option. Either a surgical minimal invasive sacroiliac osteosynthesis or conservative treatment is a possibility. Of course, both treatment options have pros and cons. This research project will randomize all patients with a FFP IIb or IIc fracture in either surgical or conservative treatment. These treatments will be evaluated at the follow-ups, 4 weeks, 4 months and 1 year after trauma. This will be evaluated with the DEMMI, Accelerometer, EQ-5D (EuroQol Quality of Live Questionnaire), radiological results, range of motion, pain-levels and reporting any postoperative complications or adverse events. Patient will be included over a period of 18 months and will be followed for at least a year. This research project aim to answer the question which treatment option for FFP type IIb and IIc is the most adequate.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Treatment of FFP type IIb and IIc
N/A

Detailed Description

Background. Fragility fractures of the pelvis are increasing in incidence. These are osteoporotic fractures, who result from a minor trauma. Typically, the weak osteoporotic bone is fractured, an the ligaments remain intact resulting in an undisplaced or minimally displaced pelvic ring. Fragility fractures of the pelvis can be divided in type I, II, III and IV. For type I the treatment method of choice is conservative. For type III and IV a surgical treatment is necessary. Only the ideal treatment for type II remains unclear. There is no consensus in whether conservative treatment or surgical treatment will have the best outcomes. Surgical treatment mostly means a minimal invasive osteosynthesis. In our hospital we use percutaneous sacroiliac screw fixation with augmentation. The screws used are perforated and fenestrated, allowing for a correct placement an cement augmentation. Preferably, this procedure is performed in our hybrid operation theatre. An intraoperative CT-scan can be performed. This treatment method has proven to be a safe method in literature. On the other hand, surgical treatment, can have complications and risks, especially in the elderly. Conservative treatment consist of mobilisation and physiotherapy. But conservative treatment can be limited because of uncontrolled pain, resulting in a long immobilisation period. Immobilisation in the elderly leads to several complications. This research project will focus on early operative intervention to reduce the immobilisation period and its negative consequences.

Study design. Recruitment of patients will find place in our emergency department and our outpatient clinic. A lot of patients with a FFP type IIb and IIc present themselves at our emergency department due to immobilising pain. All the elderly patient who complain about sacroiliac pain will receive an CT-scan. Literature showed that an conventional x-ray is not sufficient to detect sacroiliac fractures. On the other hand a lot of patient are referred to our outpatient clinic by other hospitals in our region or even general practioners. All these patients, who meet our inclusion criteria, will be asked for informed consent. After informed consent has been collected, patients will be randomised to on of the groups. The first group will receive surgical treatment and the second group will receive conservative treatment. Randomisation is performed with a vending machine. Depending on which soda can comes out, patients are assigned to the groups.

Study intervention. As stated before the are two groups in this research project. Both treatment are standard treatments. Both groups will receive a standard set of co-interventions, such as adequate analgesics and intensive physiotherapy. At our hospital a geriatric trauma centre is established. After discharge or 4 weeks after trauma a first follow-up is planned. This is primary for the treatment evaluation. Then after 4 months are second follow-up is planned with a traumatologist, physiotherapist and a geriatric specialist. At this follow-up several benchmark test are performed, such as the DEMMI, EQ 5D and an accelerometer is explained and given out. Especially this accelerometer will tell us more about the amount of mobilisation or immobilisation at home. The last follow-up will be 1 year after trauma. At all follow-ups radiological controls are performed. These will be conventional x-rays. Only in specific cases, for example prolonged pain, an CT-scan will be performed.

Data and data management. The sample size was based on the expected difference between treatment groups in improvement on the DEMMI score between baseline and 4 months follow-up. Previous studies show that the minimal clinical important difference of the DEMMI score is 10 points. This results in a sample size of 68 patients, accounted for 10% loss to follow-up.

The statistical planned analyses are primary a pearson chi-squared or fishers exact test for categorical variables or a students t or mann-whitney test. However the primary outcome will be analysed using mixed linear models with random effects. The models will be compared usin Akaike information criterium. Missing data will be imputed using multiple imputation. All analyses will be performed using SPSS version 19 or higher. A p value <0.05 is regarded as being statistically significant.

Data is stored on the protected server systems of Hospital of Lucerne. Files containing anonymous data can also be stored on the personal computers of the investigators. Data is recorded on paper and digitally. Questionnaires are on paper, but all the measurements, as the DEMMI score of range of motion will be digitally. Participants can not be identified in the CRF (Case report form). Appropriate corresponding codes are only known and accessible for the investigators.

Upon simple request by the patient, he or she will immediately be withdrawn from the study and no further date will be recorded in the study. It is guaranteed that further treatment will be equal to standard care.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
68 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Conservative or Operative Therapy in Patients With a Fragility Fracture of the Pelvis: a Prospective, Randomized Controlled Trial
Anticipated Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
Oct 30, 2023
Anticipated Study Completion Date :
Oct 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Surgical

Surgical treatment using a minimal invasive surgical method. At our hospital we perform a percutaneous sacroiliac osteosynthesis using cannulated, perforated and fenestrated screws. This procedure is preferably performed in our hybrid operation theatre, which allows for correct placement using an intraoperative CT-scan.

Procedure: Treatment of FFP type IIb and IIc
Patients will either be randomized in the surgical or conservative group.

Active Comparator: Conservative

Patients will receive individually tailored physiotherapy and analgesics if necessary.

Procedure: Treatment of FFP type IIb and IIc
Patients will either be randomized in the surgical or conservative group.

Outcome Measures

Primary Outcome Measures

  1. Mobility level [1 year]

    DEMMI (0-100, 100 is maximal mobility)

Secondary Outcome Measures

  1. Pain levels [1 year]

    VAS (visual analogue scale, 0-10, 0 means no pain)

  2. Clinical characteristics [Baseline]

    Age

  3. Clinical characteristics [Baseline]

    Gender

  4. Clinical characteristics [Baseline]

    ASA-Score (1-6, 1 is a healthy patient)

  5. Clinical characteristics [Baseline, 1 year]

    BMI

  6. Clinical characteristics [Baseline]

    Osteoporosis treatment (yes or no)

  7. Medication [Baseline, 1 year]

    Reporting what kind of medications all patients take (including steroids, anticoagulation, pain killers, et cetera)

  8. Clinical characteristics [Through study completion, an average of 1 year]

    Surgical related complications

  9. Clinical characteristics [after discharge]

    Length of hospital stay after first admission

  10. Clinical characteristics [Baseline]

    Fracture classification (FFP I - IV)

  11. Clinical characteristics [1 year]

    FES-1 (falls efficacy scale, 16-64, 16 means no fear of falling, 64 is the maximum)

  12. Clinical characteristics [1 year]

    EQ-5D (0-100, 100 is the best possible health status)

  13. Clinical characteristics [1 year]

    SPPB (short physical performance battery, 0-12, 12 is the best function)

  14. Mobility level [1 year]

    Barthel Index (0-100, 100 is completely independent)

  15. Mobility level [During 1 week after 4 Months]

    Accelerometer (this is a device that continously measures the activity level of an patient. It comes in the form of a bracelet)

  16. Mobility level [1 year]

    TUG (time up and go test)

  17. Mobility level [1 year]

    5 Chair rise

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Informed Consent as documented by signature

  • The fracture must be a fragility fracture. This means absence of high energy trauma.

  • Fragility fracture of the sacrum (FFP II b + c). Involvement of the ventral pelvic ring is not an exclusion criteria.

  • Able to walk 4 meters before fracture

Exclusion Criteria:
  • Patients who had a high energy trauma.

  • FFP I or FFP III+IV were operative therapy is recommended

  • Patient who are not operable according to the anaesthesiologist on call.

  • Open fractures.

  • Revision surgeries.

  • Absent contact information

  • Living abroad and cannot participate in follow-up visits.

  • Withdrawal from the study.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Björn-Christian Link

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Björn-Christian Link, Co-director of the orthopaedics and traumatology department, Luzerner Kantonsspital
ClinicalTrials.gov Identifier:
NCT04744350
Other Study ID Numbers:
  • FFP1
First Posted:
Feb 8, 2021
Last Update Posted:
Apr 21, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2022